RYTM

RHYTHM PHARMACEUTICALS, INC.

Next Earnings

Nov 04, 2026

Net Activity (1Y)

-$22.8M

Net Activity (90D)

-$21.0M

Insider Activity Graph

(28 shown · 86 raw)

Green/Red bubbles = daily net insider value (size = magnitude), Blue line = daily close price, E = earnings-related SEC filing

Insider trades for this company
Insider	Title	Type	Date ↓	Shares	Value
Jennifer Kayden Lee	EVP, Head of North America	Sale	2026-08-13	75,834	$8.9M
Alastair Garfield	Chief Scientific Officer	Sale	2026-08-13	7,763	$913K
Joseph Shulman	Chief Technical Officer	Sale	2026-08-13	5,079	$608K
Yann Mazabraud	EVP, Head of International	Sale	2026-08-12	57,000	$6.6M
Alastair Garfield	Chief Scientific Officer	Tax Withhold	2026-07-01	2,150	$237K
Lynn A. Tetrault		Sale	2026-06-22	37,000	$3.7M
Christopher Paul German	Corporate Controller & CAO	Sale	2026-05-15	4,643	$428K
Edward T Mathers	—	Other	2026-03-12	4,199	—
Christopher Paul German	Corporate Controller & CAO	Sale	2026-03-04	5,614	$503K
Edward T Mathers	—	Other	2026-03-02	4,198	—
Christopher Paul German	Corporate Controller & CAO	Tax Withhold	2026-03-01	342	$32K
Hunter C Smith	Chief Financial Officer	Sale	2026-02-19	4,385	$444K
Hunter C Smith	Chief Financial Officer	Sale	2026-02-17	3,569	$362K